Quadrant Capital Group’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-835
Closed -$63K 1581
2026
Q1
$63K Hold
835
﹤0.01% 1623
2025
Q4
$56.7K Hold
835
﹤0.01% 1646
2025
Q3
$47.6K Buy
+835
New +$49.5K ﹤0.01% 1693
2025
Q2
Sell
-763
Closed -$33.4K 1666
2025
Q1
$33.4K Hold
763
﹤0.01% 1864
2024
Q4
$32.8K Hold
763
﹤0.01% 1653
2024
Q3
$34.1K Hold
763
﹤0.01% 1659
2024
Q2
$29.4K Hold
763
﹤0.01% 1692
2024
Q1
$26.3K Hold
763
﹤0.01% 1728
2023
Q4
$22.1K Buy
+763
New +$17.4K ﹤0.01% 1773

Other funds holding DBD

Quadrant Capital Group's DBD Position: Q2 2026 in Review

Quadrant Capital Group sold out of Diebold Nixdorf (DBD) in Q2 2026, closing a stake of 835 shares — an estimated $63K sold.

Quadrant Capital Group first reported a position in DBD in Q4 2023 and held it in 9 quarters. The position peaked at $63K in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Quadrant Capital Group reported no remaining Diebold Nixdorf position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 835 Diebold Nixdorf shares in Q2 2026, an estimated $63K.
  • Quadrant Capital Group first reported a position in Diebold Nixdorf in Q4 2023 and held it in 9 quarters.
  • Quadrant Capital Group's Diebold Nixdorf position peaked at $63K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.